Pfizer ends deal with Celldex
Celldex Therapeutics, Inc. (Nasdaq: CLDX) says Pfizer has terminated its agreement to develop a potential brain cancer vaccine. Celldex said in a statement that Pfizer has decided that the program “is no longer a strategic priority”. feeds.bizjournals.com |
Sanofi CEO: No rush to get Genzyme
Sanofi-Aventis’ CEO said at a Wednesday conference that the company will not rush to acquire Genzyme. But Chris Viebacher said he still sees a decent chance to buy the company at a reasonable price, eventually. feeds.bizjournals.com |
Lockheed Martin gets NASA contract extension
Lockheed Martin Integrated Systems of Houston has received a six-month extension on its contract with the National Aeronautics and Space Administration. feeds.bizjournals.com |
Savvis revises 2010 guidance
Savvis Inc. on Wednesday reaffirmed and narrowed its guidance for 2010, saying it now expects revenue in the range of $917 million to $927 million. feeds.bizjournals.com |
Hacker Unlocks Kinect's 3D Camera, Augmented Reality Next
UC Davis researcher hacks Kinect to demonstrate motion sensor's ability to capture and reconstruct 3D objects in realtime. feeds.pcworld.com |